The immunogenetics of primary biliary cirrhosis: A comprehensive review

por Webb, G.J., Siminovitch, K.A., Hirschfield, G.M.
Publicado 2015

Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross‐disease cohort study

por Webb, G. J., Rahman, S. R., Levy, C., Hirschfield, G. M.
Publicado 2018

Post‐prophylaxis Toxoplasma chorioretinitis following donor–recipient mismatched liver transplantation

por Webb, G.J., Shah, H., David, M.D., Tiew, S., Beare, N., Hirschfield, G.M.
Publicado 2016

Low‐dose interleukin‐2 promotes STAT‐5 phosphorylation, T(reg) survival and CTLA‐4‐dependent function in autoimmune liver diseases

por Jeffery, H. C., Jeffery, L. E., Lutz, P., Corrigan, M., Webb, G. J., Hirschfield, G. M., Adams, D. H., Oo, Y. H.
Publicado 2017

A42 LIVE DONOR LIVER TRANSPLANTATION IN PRIMARY SCLEROSING CHOLANGITIS: AN INDICATOR OF AN ORGAN ALLOCATION SYSTEM NOT ADDRESSING PATIENT NEED

por Zheng, K, Onofrio, F, Xu, C, Chen, S, Xu, W, Vyas, M, Bingham, K, Patel, K, Lilly, L, Selzner, N, Jaeckel, E, Tsien, C, Gulamhusein, A, Hirschfield, G M, Bhat, M
Publicado 2023

The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis

por Dyson, J. K, Wilkinson, N., Jopson, L., Mells, G., Bathgate, A., Heneghan, M. A., Neuberger, J., Hirschfield, G. M., Ducker, S. J., Sandford, R., Alexander, G., Stocken, D., Jones, D. E. J.
Publicado 2016

A44 A 1000 PATIENT CANADIAN NETWORK FOR AUTOIMMUNE LIVER DISEASE EVALUATION OF CLINICAL AND DEMOGRAPHIC PATTERNS OF AUTOIMMUNE HEPATITIS

por Plagiannakos, C G, Montano-Loza, A J, Lytvyak, E, Pallotta, J, Mason, A L, Qumosani, K M, Worobetz, L, Flemming, J A, Hercun, J, Vincent, C, Cheung, A, Chen, T, Grbic, D, Swain, M G, Gulamhusein, A, Hansen, B E, Hirschfield, G M
Publicado 2023